Drug Profile
Anti-CD2 monoclonal antibody OX34
Alternative Names: CD2 antibody OX34; CD2 monoclonal antibody OX34; OX34; OX34 antibodyLatest Information Update: 23 Aug 2002
Price :
$50
*
At a glance
- Originator DKFZ; National Cancer Institute (USA)
- Developer National Cancer Institute (USA)
- Class Monoclonal antibodies
- Mechanism of Action CD2 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Transplant rejection